Amanote Research
Register
Sign In
P1.01-90 a Pilot Trial Assessing Apatinib Combined With Docetaxel (DTX) as Second-Line Chemotherapy for EGFR Negative Advanced NSCLC)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.646
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
T. Lv
Y. Song
H. Liu
L. Miao
Z. Wang
M. Shi
Publisher
Elsevier BV